Contribute Try STAT+ Today

The student-run Harvard Science Policy Group makes a pilgrimage each year to Washington, D.C., to meet with scientists who work in and around the federal government. The goal of the trip is to help students understand how science informs policy and to learn about related career options for PhD-level scientists. In the past, the group has met with scientists throughout the executive and legislative branches.

When we started to organize this year’s trip, just a week after President Trump’s inauguration, we weren’t sure what to expect. At that time there were rumors of a gag order at the Environmental Protection Agency and mass departures at the White House Office of Science and Technology Policy (OSTP). Given the president’s anti-science campaign rhetoric, which has continued since he took office, we thought that government scientists might reply to our emails by saying, “Sorry, we can’t meet with you. We are too busy looking for new jobs.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Sounds like an effort at wistfully positive spin on a positively grim situation.

Comments are closed.